Similar Search Results

Cost Effectiveness of Enoxaparin as Prophylaxis against Venous Thromboembolic Complications in Acutely Ill Medical Inpatients

Schädlich, Peter; Kentsch, Michael; Weber, Manfred; … - In: PharmacoEconomics 24 (2006) 6, pp. 571-591

<Emphasis Type="Bold">Objective: To estimate, from the hospital perspective in Germany, the cost effectiveness of the low-molecular-weight heparin (LMWH) subcutaneous enoxaparin sodium 40mg once daily (ENOX) relative to no pharmacological prophylaxis (NPP) and relative to subcutaneous unfractionated heparin (UFH)...</emphasis>

Persistent link: https://www.econbiz.de/10011001767

Cost Effectiveness of Enoxaparin as Prophylaxis against Venous Thromboembolic Complications in Acutely Ill Medical Inpatients: Modelling Study from the Hospital Perspective in Germ...

Schadlich, Peter K.; Kentsch, Michael; Weber, Manfred; … - In: PharmacoEconomics 24 (2006) 6, pp. 571-591

Objective: To estimate, from the hospital perspective in Germany, the cost effectiveness of the low-molecular-weight heparin (LMWH) subcutaneous enoxaparin sodium 40mg once daily (ENOX) relative to no pharmacological prophylaxis (NPP) and relative to subcutaneous unfractionated heparin (UFH)...

Persistent link: https://www.econbiz.de/10004990355